Sign up to save your podcasts
Or
Share The Briefing, April 26th: ATAI Files S-1
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Briefing, April 26th: ATAI Files S-1
In this week’s briefing:
ATAI aims to raise $100 million in IPO
Mushroom bevvies are here
MDMA and psilocybin may still be rescheduled in Australia
PharmaTher to study ketamine for Parkinson’s
Beckley Psytech + Fluence create psychedelic therapy training program
View all episodes
By Report on PsychedelicsIn this week’s briefing:
ATAI aims to raise $100 million in IPO
Mushroom bevvies are here
MDMA and psilocybin may still be rescheduled in Australia
PharmaTher to study ketamine for Parkinson’s
Beckley Psytech + Fluence create psychedelic therapy training program